$Veru(VERU)$VERU received FDA clarity supporting enobosarm plus GLP-1 RA as a combination obesity therapy, with incremental fat loss accepted as a primary endpoint; following positive Phase 2b QUALITY results showing preserved lean mass and physical function, Veru will i...